Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined 4-Day ATG Regimen for aGVHD Prophylaxis in MSD-PBSCT
NCT05214066Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2019
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT05214066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05214066.